Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 7;22(7):58.
doi: 10.1007/s11864-021-00855-y.

Cardio-oncology Training in the COVID-19 Era

Stephanie Feldman  1 , Jennifer Liu  1   2 , Richard Steingart  1   2 , Dipti Gupta  3   4
Affiliations
Review

Cardio-oncology Training in the COVID-19 Era

Stephanie Feldman et al. Curr Treat Options Oncol. .

Abstract

Cardio-oncology is a field dedicated to the prevention, diagnosis, and management of cardiovascular disease in cancer patients before, during, and after cancer therapy. It is an emerging field with limited opportunities for structured education and training. In the year 2021, we cannot define the requirements of cardio-oncology training without acknowledging the impact of the global coronavirus disease 19 (COVID-19) pandemic. While this pandemic poses significant health risks to patients with cancer and cardiovascular disease as well as the providers who care for them, it also allows novel opportunities for the nascent field of cardio-oncology to readily adapt. In this article, we detail how the COVID-19 pandemic has impacted all aspects of cardio-oncology training, how programs and trainees can adapt to these challenges, and how lessons learned from the COVID-19 era can continue to positively impact cardio-oncology training for the foreseeable future.

Keywords: COVID-19; Cardio-oncology; Cardiotoxicity; Fellowship training; Medical education.

PubMed Disclaimer

Conflict of interest statement

Stephanie A. Feldman declares that she has no conflict of interest.

Jennifer Liu has received consultant fees from Pfizer, Caption Health, Philips Medical, and for service on the Data and Safety Monitoring Board (DSMB) for Caelum Biosciences, Inc.

Richard Steingart declares that he has no conflict of interest.

Dipti Gupta declares that she has no conflict of interest.

Figures

Fig. 1
Fig. 1
Core components of cardio-oncology training in the COVID-19 era.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi: 10.3322/caac.21654. - DOI - PubMed
    1. Lenihan DJ, Hartlage G, DeCara J, Blaes A, Finet JE, Lyon AR, et al. Cardio-oncology training: a proposal from the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary Specialty. J Card Fail. 2016;22(6):465–471. doi: 10.1016/j.cardfail.2016.03.012. - DOI - PubMed
    1. Johnson MN, Steingart R, Carver J. How to develop a cardio-oncology fellowship. Heart Fail Clin. 2017;13(2):361–366. doi: 10.1016/j.hfc.2016.12.012. - DOI - PubMed
    1. Alvarez-Cardona JA, Ray J, Carver J, Zaha V, Cheng R, Yang E, et al. Cardio-oncology education and training: JACC Council Perspectives. J Am Coll Cardiol. 2020;76(19):2267–2281. doi: 10.1016/j.jacc.2020.08.079. - DOI - PMC - PubMed
    1. Johns Hopkins University & Medicine. Coronavirus Resource Center 2021 [Available from: https://coronavirus.jhu.edu/. Accessed March 15, 2021

MeSH terms